Judging from body language I would not think they are working on heparins for Teva, my bet would be antibodies. but who knows?
Unlike Momenta, Procognia is not a drug developing company. They are more of sub contractors for glycoanalysis projects. Customers can pay for analysis work or make them a minor partner (Teva).
Bristol is still evaluating the technology and it is not known yet if they will have a long term agreement like Teva.
The third agreement is with Nutricognia in the R&D and manufacture of nutritional commodities, they will get fat royalties for 15 years but this is not a big issue for the time being.
They also have a marketing agreement with Qiagen for their low resolution device for scientific research, not a big issue either.